Effect of two oral contraceptives containing 30 μg ethinylestradiol and 75 μg gestodene or 150 μg desogestrel upon various hormonal parameters
Authors:
- F. HeidtFHF. Heidt
- H. KuhlHKH. Kuhl
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 38 (6) , 593-603
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Gestoden, an innovative progestogenAdvances in Contraception, 1987
- A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levelsContraception, 1985
- Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptivesContraception, 1984
- Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrelContraception, 1984
- Blood prolactin levels: Influence of age, menstrual cycle and oral contraceptivesContraception, 1983
- Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrelContraception, 1983
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- Ethinylestradiol and a New Progestogen (Desogestrel) in a Low-Dose Combination: Effects on Pituitary-Gonadal Function, Serum Sex-Hormone Binding Globulin Capacity, Endometrium and Cervical Mucus1982
- Further studies on pituitary and ovarian function in women receiving hormonal contraceptionContraception, 1981
- Comparison of the Effects of Contraceptive Steroid Formulations Containing Two Doses of Estrogen on Pituitary FunctionFertility and Sterility, 1978